Abstract
Indirect evidence suggests a crucial role for the fibrinolytic system and its physiological triggers, tissue-type (t-PA) and urokinase-type (u-PA) plasminogen activator, in many proteolytic processes. Inactivation of the t-PA gene impairs clot lysis and inactivation of the u-PA gene results in occasional fibrin deposition. Mice with combined t-PA and u-PA deficiency suffer extensive spontaneous fibrin deposition, with its associated effects on growth, fertility and survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Astrup, T. in Progress in Chemical Fibrinolysis and Thrombolysis Vol. 3 (eds Davidson, J.F., Rowan, R. M., Samama, M. M. & Desnoyers, P. C.) 1–57 (Raven, New York, 1987).
Collen, D. & Lijnen, H. R. Blood 78, 3114–3124 (1991).
Vassalli, J. D., Sappino, A. P. & Belin, D. J. clin. Invest. 88, 1067–1072 (1991).
Kluft, C. Tissue-type Plasminogen Activator (t-PA): Physiological and Clinical Aspects Vol. 1 (ed. Kluft, C.) 47–79 (CRC, Boca Raton, Florida, 1988).
Blasi, F., Vassalli, J.-D. & Danø, K. J. Cell Biol. 104, 801–804 (1987).
Saksela, O. & Rifkin, D. B. A. Rev. Cell Biol. 4, 93–126 (1988).
Moscatelli, D. & Rifkin, D. B. Biochim. biophys. Acta 948, 67–85 (1988).
Unkeless, J. C., Gordon, S. & Reich, E. J. exp. Med. 139, 834–850 (1974).
Freyria, A. M., Paul, J., Belleville, J., Broyer, P. & Etoy, R. Comp. Biochem. Physiol. 99, 517–524 (1991).
Baker, M. S., Bleakley, P., Woodrow, G. C. & Doe, W. F. Cancer Res. 50, 4676–4684 (1990).
Huarte, J., Belin, D. & Vassalli, J. D. Cell 43, 551–558 (1985).
Tsafriri, A., Bicsak, T. A., Cajander, S. B., Ny, T. & Hsueh, A. J. W. Endocrinology 124, 415–421 (1989).
Wagner, E. F. EMBO J. 9, 3024–3032 (1990).
Morioka, S., Lazarus, G. S., Baird, J. L. & Jensen, P. J. J. Invest. Dermatol. 88, 418–423 (1987).
Danø, K. et al. Adv. Cancer Res. 44, 139–266 (1985).
Huarte, J., Belin, D., Bosco, D., Sappino, A. P. & Vassalli, J. D. J. Cell Biol. 104, 1281–1289 (1987).
Sappino, A. P., Huarte, J., Belin, D. & Vassalli, J. D. J. Cell biol. 109, 2471–2479 (1989).
Strickland, S., Reich, E. & Sherman, M. I. Cell 9, 231–240 (1976).
Menoud, P. A., Debrot, S. & Schowing, J. Roux Arch. dev. Biol. 198, 219–226 (1989).
Denker, H. W. Adv. Anat. Embryol. Cell biol. 53, 3–123 (1977).
Nilsson, I. M., Ljungner, H. & Tengborn, L. Br. Med. J. Clin. Res. Ed. 290, 1453–1456 (1985).
Juhan-Vague, I. & Collen, D. Ann. Epidemiol. 2, 427–438 (1992).
Tomooka, S., Border, W. A., Marshall, B. C. & Nobel, N. A. Kidney Int. 42, 1462–1469 (1992).
Idell, S. et al. J. clin. Invest. 84, 695–705 (1989).
Stassen, J. M., Vanlinthout, I., Lijnen, H. R. & Colien, D. Fibrinolysis 4 (suppl. 2) 15–21 (1990).
Carmeliet, P. et al. J. clin. Invest. 92, 2756–2760 (1993).
Granelli-Piperno, A., Vassalli, J. D. & Reich, E. J. exp. Med. 146, 1693–1706 (1977).
Canipari, R., O'Connell, M. L., Meyer, G. & Strickland, S. J. Cell biol. 105, 977–981 (1987).
Busso, N., Huarte, J., Vassalli, J. D., Sappino, A. P. & Belin, D. J. biol. Chem. 264, 7455–7457 (1989).
Ossowski, L., Biegel, D. & Reich, E. Cell 16, 929–940 (1979).
Lala, P. K. & Graham, C.H. Cancer Metastasis Rev. 9, 369–379 (1990).
Astrup, T. & Müllertz, S. Arch. Biochem. Biophys. 40, 346–351 (1952).
Verheijen, J. H., Chang, G. T. G. & Kluft, C. Thromb. Haemostasis 51, 392–395 (1984).
Tybulewicz, V. L., Crawford, C. E., Jackson, P. K., Bronson, R. T. & Mulligan, R. C. Cell 65, 1153–1163 (1991).
Rickles, R. J., Darrow, A. L. & Strickland, S. J. biol. Chem. 263, 1563–1569 (1988).
Peng, F., Ohlsson, M. & Ny, T. J. biol. Chem. 265, 2022–2027 (1990).
Carmeliet, P. et al. J. clin. Invest. 92, 2746–2755 (1993).
Degen, S. J., Heckel, J. L., Reich, E. & Degen, J. L. Biochemistry 26, 8270–8279 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carmeliet, P., Schoonjans, L., Kieckens, L. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419–424 (1994). https://doi.org/10.1038/368419a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/368419a0
This article is cited by
-
The role of fibrinolysis in vascular diseases in UK biobank
Journal of Thrombosis and Thrombolysis (2023)
-
tPA-NMDAR Signaling Blockade Reduces the Incidence of Intracerebral Aneurysms
Translational Stroke Research (2022)
-
Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke
Translational Stroke Research (2022)
-
Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
Journal of Neuroinflammation (2021)
-
Therapeutics targeting the fibrinolytic system
Experimental & Molecular Medicine (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.